TGA Approval

REBLOZYL luspatercept 25 mg powder for injection vial (334510)

ARTG ID

334510

ARTG Name

REBLOZYL luspatercept 25 mg powder for injection vial

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

August 30, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

Ingredient Name

luspatercept

Empowering clinical research with data-driven insights and AI-powered tools.

REBLOZYL luspatercept 25 mg powder for injection vial (334510) - TGA 批准文号 | MedPath